A systematic review of the utility of anticonvulsant pharmacotherapy in the treatment of vulvodynia pain

Journal of Sexual Medicine

Volumn 10, Issue 8, 2013, Pages 2000-2008

  Leo, Raphael J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Anticonvulsants; Neuropathic Pain Disorder; Pharmacotherapy; Sexual Pain Disorder; Treatment; Vestibulodynia; Vulvodynia

Indexed keywords

CARBAMAZEPINE; CITALOPRAM; GABAPENTIN; LAMOTRIGINE; PREGABALIN; 4 AMINOBUTYRIC ACID; AMINE; ANTICONVULSIVE AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

ANTICONVULSANT THERAPY; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FOLLOW UP; HEADACHE; HUMAN; MCGILL PAIN QUESTIONNAIRE; METHODOLOGY; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; RASH; REMISSION; SLEEP DISORDER; SOMNOLENCE; SYSTEMATIC REVIEW; TREATMENT DURATION; VULVODYNIA; FEMALE; MIDDLE AGED; WITHDRAWAL SYNDROME;

AMINES; ANTICONVULSANTS; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MIDDLE AGED; SUBSTANCE WITHDRAWAL SYNDROME; VULVODYNIA;

EID: 84881092663     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12200     Document Type: Article

References (42)

1. Moyal-Barracco M, Lynch PJ. 2003 ISSVD terminology and classification vulvodynia-A historical perspective. J Reprod Med 2004;49:772-777.
2. Goetsch MF. Vulvar vestibulitis: Prevalence and historic features in a general gynecologic practice population. Am J Obstet Gynecol 1991;164:1609-1616.
3. Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: Have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc 2003;58:82-88.
4. Bachmann GA, Rosen R, Pinn VW, Utian WH, Ayers C, Basson R, Binik YM, Brown C, Foster DC, Gibbons JM Jr, Goldstein I, Graziottin A, Haefner HK, Harlow BL, Spadt SK, Leiblum SR, Masheb RM, Reed BD, Sobel JD, Veasley C, Wesselmann U, Witkin SS. Vulvodynia: A state of-the-art consensus on definitions, diagnosis and management. J Reprod Med 2006;51:447-456.
5. Groysman V. Vulvodynia: New concepts and review of the literature. Dermatol Clin 2010;28:681-696.
6. Ponte M, Klemperer E, Sahay A, Chren MM. Effects of vulvodynia on quality of life. J Am Acad Dermatol 2009;60:70-76.
7. Andrews JC. Vulvodynia interventions-Systematic review and evidence grading. Obstet Gynecol Surv 2011;66:299-315.
8. Bohm-Starke N, Hilliges M, Brodda-Jansen G, Rylander E, Torebjork E. Psychophysical evidence of nociceptor sensitization in vulvar vestibulitis syndrome. Pain 2001;94:177-183.
9. Foster DC, Hasday JD. Elevated tissue levels of interleukin-1 beta and tumor necrosis factor-alpha in vulvar vestibulitis. Obstet Gynecol 1997;89:291-296.
10. Foster DC, Piekarz KH, Murant TI, LaPoint R, Haidaris CG, Phipps RP. Enhanced synthesis of proinflammatory cytokines by vulvar vestibular fibroblasts: Implications for vulvar vestibulitis. Am J Obstet Gynecol 2007;196:346e1-3468.
11. Westrom LV, Willen R. Vestibular nerve fiber proliferation in vulvar vestibulitis syndrome. Obstet Gynecol 1998;91:572-576.
12. Attal N, Cruccu G, Haanpaa M, Hansson P, Jensen TS, Nurmikko T, Sampaio C, Sindrup S, Wiffen P. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006;13:1153-1169.
13. Haefner HK, Collins ME, Davis GD, Edwards L, Foster DC, Hartmann ED, Kaufman RH, Lynch PJ, Margesson LJ, Moyal-Barracco M, Piper CK, Reed BD, Stewart EG, Wilkinson EJ. The vulvodynia guideline. J Low Genit Tract Dis 2005;9:40-51.
14. Updike GM, Wiesenfeld HC. Insight into the treatment of vulvar pain: A survey of clinicians. Am J Obstet Gynecol 2005;193:1404-1409.
15. Leo RJ, Dewani S. A systematic review of the utility of antidepressant pharmacotherapy in the treatment of vulvodynia pain. J Sex Med 13 Sep 2012 [Epub ahead of print] doi: 10.1111/j.1743-6109.2012.02915.x.
16. Backonja MM. Anticonvulsants (antineuropathics) for neuropathic pain syndromes. Clin J Pain 2000;16(suppl):67-72.
17. Blackburn-Munro G, Erichsen HK. Antiepileptics and the treatment of neuropathic pain: Evidence from animal models. Curr Pharm Des 2005;11:2961-2976.
18. Sator-Katzenschlager SM, Scharbert G, Kress HG, Frickey N, Ellend A, Gleiss A, Kozek-Langenecker SA. Chronic pelvic pain treated with gabapentin and amitriptyline: A randomized controlled pilot study. Wien Klin Wochenschr 2005;117:761-768.
19. Meltzer-Brody SE, Zolnoun D, Steege JF, Rinaldi KL, Leserman J. Open-label trial of lamotrigine focusing on efficacy in vulvodynia. J Reprod Med 2009;54:171-178.
20. Reed BD, Haefner HK, Cantor L. Vulvar dysesthesia (vulvodynia): A follow-up study. J Reprod Med 2003;48:409-416.
21. Moher D, Schulz KF, Altman D, for the CONSORT Group. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285:1987-1991.
22. Stroup DF, Berlin JA, Morton SC, for the Meta-Analysis of Observational Studies in Epidemiology [MOOSE] group. Meta-analysis of observational studies in epidemiology-A proposal for reporting. JAMA 2000;283:2008-2012.
23. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ, for the GRADE Working Group. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-926.
24. Lohr KN. Rating the strength of scientific evidence: Relevance for quality improvement programs. Int J Qual Health Care 2004;16:9-18.
25. Ventolini G, Barhan S, Duke J. Vulvodynia, a step-wise therapeutic prospective cohort study. J Obstet Gynaecol 2009;29:648-650.
26. Ben-David B, Friedman M. Gabapentin therapy for vulvodynia. Anesth Analg 1999;89:1459-1460.
27. Boardman LA, Cooper AS, Blais LR, Raker CA. Topical gabapentin in the treatment of localized and generalized vulvodynia. Obstet Gynecol 2008;112:579-585.
28. Jeon Y, Kim Y, Shim B, Yoon H, Park Y, Shim B, Jeong W, Lee D. A retrospective study of the management of vulvodynia. Korean J Urol 2013;54:48-52.
29. Harris G, Horowitz B, Borgida A. Evaluation of gabapentin in the treatment of generalized vulvodynia, unprovoked. J Reprod Med 2007;52:103-106.
30. Bates CM, Timmins DJ. Vulvodynia-New and more effective approaches to therapy. Int J STD AIDS 2002;13:210-212.
31. Jerome L. Pregabalin-induced remission in a 62-year-old woman with a 20-year history of vulvodynia. Pain Res Manag 2007;12:212-214.
32. Hamandi K, Sander JW. Pregabalin: A new antiepileptic drug for refractory epilepsy. Seizure 2006;15:73-78.
33. Wilton LV, Shakir S. A postmarketing surveillance study of gabapentin as add-on therapy for 3, 100 patients in England. Epilepsia 2002;43:983-992.
34. Wong IC, Mawer GE, Sander JW. Adverse event monitoring in lamotrigine patients: A pharmacoepidemiologic study in the United Kingdom. Epilepsia 2001;42:237-244.
35. Scheinfeld N. The role of gabapentin in treating diseases with cutaneous manifestations and pain. Int J Dermatol 2003;42:491-495.
36. Foster DC, Kotok MB, Huang LS, Watts A, Oakes D, Howard FM, Stodgell CJ, Dworkin RH. The tampon test for vulvodynia treatment outcomes research reliability, construct validity, and responsiveness. Obstet Gynecol 2009;113:825-832.
37. Giesecke J, Reed BD, Haefner HK, Giesecke T, Clauw DJ, Gracely RH. Quantitative sensory testing in vulvodynia patients and increased peripheral pressure pain sensitivity. Obstet Gynecol 2004;104:126-133.
38. Reed BD, Haener HK, Sen A, Gorenflo DW. Vulvodynia incidence and remission rates among adult women: A 2-year follow-up study. Obstet Gynecol 2008;112:231-237.
39. Davis CE. The effect of regression to the mean in epidemiologic and clinical studies. Am J Epidemiol 1976;104:493-498.
40. Hayes RJ. Methods for assessing whether change depends on initial value. Stat Med 1988;7:915-927.
41. Schmidt S, Bauer A, Greif C, Merker A, Elsner P, Strauss B. Vulvar pain-Psychological profiles and treatment responses. J Reprod Med 2001;46:377-384.
42. Spoelstra SK, Dijkstra JR, van Driel MF, Weijmar Schultz WC. Long-term results of an individualized, multifaceted, and multidisciplinary therapeutic approach to provoked vestibulodynia. J Sex Med 2011;8:489-496.